LB0002 a first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis

Sangita Khatri, J. Hansen, Mads Hartvig Clausen, T. W. Kragstrup, S. C. Hung, E. Mellins, Kira Astakhova

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Fingerprint

Dive into the research topics of 'LB0002 a first in class therapeutic nanoparticle for specific targeting of anti-citrullinated protein antibody ameliorates serum transfer and collagen induced arthritis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology